SER stock

Serina Therapeutics Inc (SER) financials · rev $130.0K

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Serina Therapeutics Inc (SER) rev $130.0K.

Cached annual income statement
LineFY2025FY2023
Revenue$130.0K$142.0K
Cost of RevenueN/A$40.0K
Gross ProfitN/A$102.0K
Operating Income-$24.0M-$9.89M
Net Income-$19.2M-$14.8M
EPS (Diluted)-$1.91-$13.72
Cached annual balance sheet
LineFY2025FY2024
Total Assets$6.95M$6.72M
Current Assets$6.08M$5.68M
Cash & Equivalents$3.06M$3.67M
PP&E$465.0K$501.0K
Total Liabilities$6.99M$6.22M
Current Liabilities$3.56M$2.37M
Shareholders' Equity-$37.0K$641.0K
Retained Earnings-$63.5M-$44.3M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$18.0M-$17.1M
CapEx$59.0K$22.0K
Investing Cash Flow-$59.0K-$22.0K
Financing Cash Flow$17.4M$13.2M
Net Change in Cash-$616.0K-$3.95M
Free Cash Flow-$18.0M-$17.2M
These statements as JSON? API free 100/day

FAQ

What is SER P/E and revenue?

Serina Therapeutics Inc (SER) rev $130.0K.

What is SER revenue?

Serina Therapeutics Inc last cached revenue is $130.0K (FY2025).

Is SER profitable?

Serina Therapeutics Inc last cached net income is -$19.2M (FY2025).

What are SER total assets?

Serina Therapeutics Inc last cached total assets are $6.95M (FY2025).

What is SER free cash flow?

Serina Therapeutics Inc last cached free cash flow is -$18.0M (FY2025).

Not investment advice. Cached statements, not a live tape.